Skip to main content
. 2020 Jul 9;9(17):6111–6121. doi: 10.1002/cam4.3253

TABLE 6.

Responsiveness

Improvement P‐value a Deterioration P‐value a
N Median score [IQR] N Median score [IQR]
T1 T2 T1 T2
Pain 41 3 [2‐5] 2 [0‐3] .0028 59 0 [0‐2] 4 [2‐6] <.0001
Sleeping problems 51 4 [2‐7] 1 [0‐2] <.0001 53 0 [0‐2] 3 [2‐5] <.0001
Anorexia 45 5 [2‐7] 2 [0‐5] .011 39 1 [0‐5] 5 [3‐7] <.0001
Abnormal stool
Diarrhea 23 5 [2‐6] 2 [0‐3] .015 36 1 [0‐3] 5 [2‐6] <.0001
Obstipation 26 5 [4‐6] 2 [1‐5] .005 46 0 [0‐1] 5 [3‐7] <.0001
Nausea 24 3 [2‐5] 1 [0‐2] .00069 50 0 [0‐1] 3 [1‐4] <.0001
Dyspnea 13 3 [2‐4] 0 [0‐2] .019 28 0 [0‐0] 3 [2‐5] <.0001
Fatigue 38 4 [3‐5] 2 [1‐3] .00016 70 1 [0‐3] 4 [2‐5] <.0001
Anxiety 31 3 [2‐5] 1 [0‐2] <.0001 35 0 [0‐2] 3 [2‐5] <.0001
Depressed mood 21 4 [3‐5] 1 [0‐3] <.0001 42 0 [0‐1] 3 [2‐5] <.0001

T1=first concurrent DT&PC and USD; T2=subsequent concurrent DT&PC and USD.

a

Wilcoxon test.